Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
An intravenous piggyback (IVPB) is a method of giving a medication through a small secondary fluid container connected to a primary intravenous line. The medication is diluted in a compatible solution and infused over a prescribed period. IVPB administration is commonly used for intermittent doses rather than continuous treatment. The primary line can maintain venous access between medication doses.
read more about intravenous piggyback ...Intravenous piggyback infusions are used for medicines that need to enter the bloodstream gradually over a set period. Common examples include certain antibiotics, electrolytes, and other medications that cannot be given safely as a rapid intravenous push. The prescribed concentration and infusion time depend on the drug and the patient's condition. Some medications require a dedicated line because they are incompatible with other fluids or drugs.
The secondary medication container is connected to an access port on the primary intravenous tubing. In a traditional gravity setup, the secondary container is positioned above the primary fluid so the medication infuses first. A back-check valve helps prevent the primary fluid from flowing into the secondary container. Smart pumps can also control the secondary infusion and return to the primary infusion after the dose is complete.
A healthcare professional verifies the medication order, patient identity, dose, solution, compatibility, infusion rate, and vascular access before administration. The secondary tubing is prepared according to the product instructions and facility procedure. The infusion pump or flow-control device is programmed for the prescribed volume and time. The patient and intravenous site are monitored during and after the infusion.
Potential problems include incorrect pump programming, incompatible solutions, blocked tubing, infiltration, phlebitis, infection, and incomplete delivery of the medication. Residual drug can remain in the tubing when the line is not managed correctly. A secondary infusion can also fail when the tubing, container height, clamps, or pump settings are incorrect. Trained personnel follow compatibility, flushing, labeling, and monitoring procedures to reduce these risks.
No. An IV piggyback delivers diluted medication over a prescribed infusion period, while an IV push introduces a smaller volume directly into the intravenous line over a shorter time. The approved method depends on the medication.
In many secondary setups, the primary fluid pauses while the piggyback medication infuses and resumes afterward. The exact flow pattern depends on the pump, tubing configuration, and clinical order.
No. The medication must be suitable for intermittent infusion and compatible with the diluent, tubing, and other intravenous fluids. Product instructions and clinical compatibility references guide administration.
Flushing can move residual medication from the tubing into the bloodstream and help maintain line patency. The appropriate solution and volume depend on the medication, access device, and facility procedure.
Adverse Drug Reactions. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK599521/. Date Accessed August 5, 2026.
Idiosyncratic Adverse Drug Reactions: Current Concepts. Chemical Research in Toxicology (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC3639727/. Date Accessed August 5, 2026.
In Vitro Testing for Diagnosis of Idiosyncratic Adverse Drug Reactions: Implications for Pathophysiology. Toxicological Sciences (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC4594732/. Date Accessed August 5, 2026.
Pharmacogenetics of Idiosyncratic Adverse Drug Reactions. Pharmacogenomics (PubMed). https://pubmed.ncbi.nlm.nih.gov/20020273/. Date Accessed August 5, 2026.
Drug Allergy: Diagnosis and Management of Drug Allergy in Adults, Children and Young People. National Institute for Health and Care Excellence (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK248066/. Date Accessed August 5, 2026.